Abstract:Background: Exendin-4 is an incretin mimetic agent approved for type 2 diabetes treatment. However, the required frequent injections restrict its clinical application. Here, the potential use of chitosan-coated poly (d,l-lactide-co-glycolide) (CS-PLGA) nanoparticles was investigated for intestinal delivery of exendin-4.Methods and results: Nanoparticles were prepared using a modified water-oil-water (w/o/w) emulsion solvent-evaporation method, followed by coating with chitosan. The physical properties, particle size, and cell toxicity of the nanoparticles were examined. The cellular uptake mechanism and transmembrane permeability were performed in Madin-Darby canine kidney-cell monolayers. Furthermore, in vivo intraduodenal administration of exendin-4-loaded nanoparticles was carried out in rats. The PLGA nanoparticle coating with chitosan led to a significant change in zeta potential, from negative to positive, accompanied by an increase in particle size of similar to 30 nm. Increases in both the molecular weight and degree of deacetylation of chitosan resulted in an observable increase in zeta potential but no apparent change in the particle size of similar to 300 nm. Both unmodified PLGA and chitosan-coated nanoparticles showed only slight cytotoxicity. Use of different temperatures and energy depletion suggested that the cellular uptake of both types of nanoparticles was energy-dependent. Further investigation revealed that the uptake of PLGA nanoparticles occurred via caveolin-mediated endocytosis and that of CS-PLGA nanoparticles involved both macropinocytosis and clathrin-mediated endocytosis, as evidenced by using endocytic inhibitors. However, under all conditions, CS-PLGA nanoparticles showed a greater potential to be transported into cells, as shown by flow cytometry and confocal microscopy. Transmembrane permeability analysis showed that unmodified and modified PLGA nanoparticles could improve the transport of exendin-4 by up to 8.9-and 16.5-fold, respectively, consistent with the evaluation in rats.Conclusion: The chitosan-coated nanoparticles have a higher transport potential over both free drug and unmodified particles, providing support for their potential development as a candidate oral delivery agent for exendin-4.

Preparation of exendin-4 microspheres and its release properties in vitro

Decoration and Application of PLGA Microspheres

Preparation, Characterization, and Pharmacodynamics of Exenatide-Loaded Poly(DL-lactic-co-glycolic Acid) Microspheres

Preparation, Characterization and in Vitro Evaluation of IVM Loaded Poly(lactic-Co-Glycolic Acid) (PLGA) Microspheres

Preparation, Characterization And In Vitro Release Properties Of Ibuprofen-Loaded Microspheres Based On Polylactide, Poly(Epsilon-Caprolactone) And Their Copolymers

Preparation, characterization and in vitro release properties of ibuprofen-loaded microspheres based on polylactide, poly(ε-caprolactone) and their copolymers

Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions.

[Preparation, Characterization and Drug Release Characteristics of Poly(lactide)(pl)/poly(lactide-Co-polyethylene Glycol)(pleg) Blend Microspheres].

Exendin-4 Loaded Nanoparticles with a Lipid Shell and Aqueous Core Containing Micelles for Enhanced Intestinal Absorption.

Preparation, Characterization, and in Vitro and in Vivo Investigation of Chitosan-Coated Poly (D,l-Lactide-co-glycolide) Nanoparticles for Intestinal Delivery of Exendin-4

Bioactive Glass and PLGA Composite Microspheres, a Promising Efficient Carrier for Exenatide Delivery

Exenatide Loaded PLGA Microspheres for Long-Acting Antidiabetic Therapy: Preparation, Characterization, Pharmacokinetics and Pharmacodynamics

Preparation of sPLLA/LP microspheres and its in vitro release properties

PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo

Preparation of tolterodine PLGA micorspheres and its in vitro release properties

Development of Composite PLGA Microspheres Containing Exenatide-Encapsulated Lecithin Nanoparticles for Sustained Drug Release.

A method to prepare PLGA sustained-release microspheres

Preparation of BSA-PLG Microspheres by S/W/O/W Method

In Vitro Degradation and Controlled Release Behavior of D,L-PLGA50 and PCL-b-D,L-PLGA50 Copolymer Microspheres.

Preparation of Poly(lactide-Co-glycolide) Microspheres and Evaluation of Pharmacokinetics and Tissue Distribution of BDMC-PLGA-MS in Rats.

Recent Advances in the Preparation Progress of Protein/peptide Drug Loaded PLA/PLGA Microspheres.